Research
Hormonal
GLP-1 receptor agonists improve glycemic control, promote significant weight loss, and reduce cardiovascular events in patients with type 2 diabetes.
If you have type 2 diabetes and heart risks, GLP-1 injections can help lower blood sugar, lose weight, and protect your heart.
StrongSupportsVERY_HIGH confidence
Glucagon-like peptide-1 (GLP-1) receptor agonists allow better control of glycemia, promote weight loss and reduce the risk of cardiovascular events.
Why this rating
Supported by multiple large, landmark randomized controlled trials (LEADER, SUSTAIN-6, REWIND, PIONEER 6).
Source
Recent advances in the treatment of type 2 diabetes mellitus using new drug therapies
Keong Chong et al. · The Kaohsiung Journal of Medical Sciences · 2024
narrative_reviewCited 49×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →